Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Phathom Pharmaceuticals (PHAT) Asset Utilization Ratio: 2022-2025

Historic Asset Utilization Ratio for Phathom Pharmaceuticals (PHAT) over the last 3 years, with Sep 2025 value amounting to 0.60.

  • Phathom Pharmaceuticals' Asset Utilization Ratio rose 706.93% to 0.60 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.60, marking a year-over-year increase of 706.93%. This contributed to the annual value of 0.14 for FY2024, which is 5817.91% up from last year.
  • As of Q3 2025, Phathom Pharmaceuticals' Asset Utilization Ratio stood at 0.60, which was up 43.26% from 0.42 recorded in Q2 2025.
  • In the past 5 years, Phathom Pharmaceuticals' Asset Utilization Ratio registered a high of 0.60 during Q3 2025, and its lowest value of -0.22 during Q1 2023.
  • In the last 3 years, Phathom Pharmaceuticals' Asset Utilization Ratio had a median value of -0.00 in 2024 and averaged 0.07.
  • Data for Phathom Pharmaceuticals' Asset Utilization Ratio shows a peak YoY soared of 75,005.50% (in 2025) over the last 5 years.
  • Over the past 4 years, Phathom Pharmaceuticals' Asset Utilization Ratio (Quarterly) stood at -0.15 in 2022, then skyrocketed by 41.69% to -0.09 in 2023, then soared by 266.27% to 0.14 in 2024, then soared by 706.93% to 0.60 in 2025.
  • Its last three reported values are 0.60 in Q3 2025, 0.42 for Q2 2025, and 0.24 during Q1 2025.